Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development

Kidney International

Volumn 63, Issue 3, 2003, Pages 835-844

  Miyazaki, Yoichi ^b   Oshima, Keisuke ^b   Fogo, Agnes ^b   Ichikawa, Iekuni ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Apoptosis; Bone morphogenetic protein; Chemotaxis; Explant culture; Metanephric mesenchyme; Mouse; Mutant; Smooth muscle

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXD 1; TRANSCRIPTION FACTOR PAX 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EXPLANT; GENE EXPRESSION; HETEROZYGOSITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY DEVELOPMENT; MALE; MESENCHYME CELL; MOUSE; MULTICYSTIC DYSPLASTIC KIDNEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; URETER; URINARY TRACT;

EID: 12244274327     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00834.x     Document Type: Article

References (25)

1. HOGAN BLM: Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594, 1996
2. MIYAZAKI Y, OSHIMA K, FOGO A, et al: Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest 105:863-873, 2000
3. POPE JC, IV, BROCK JW, III, ADAMS MC, et al: How they begin and how they end: Classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 10:2018-2028, 1999
4. MACKIE GG, STEPHENS FD: Duplex kidneys: A correlation of renal dysplasia with position of the ureteral orifice. J Urol 114:274-280, 1975
5. DUDLEY AT, ROBERTSON EJ: Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Develop Dynam 208:349-362, 1997
6. DEWULF N, VERSCHUEREN K, LONNOY O, et al: Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136:2652-2663, 1995
7. LAWSON KA, DUNN NR, ROELEN BA, et al: Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 13:424-436, 1999
8. FURUTA Y, PISTON DW, HOGAN BLM: Bone Morphogenetic Proteins (BMPs) as regulators of dorsal forebrain development. Development 124:2203-2212, 1997
9. NAGATA M, NAKAUCHI H, NAKAYAMA K, et al: Apoptosis during an early stage of nephrogenesis induces renal hypoplasia in bcl-2-deficient mice. Am J Pathol 148:1601-1611, 1996
10. LUO G, HOFMANN C, BRONCKERS ALJJ, et al: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820, 1995
11. RAATIKAINEN-AHOKAS A, HYTONEN M, TENHUNEN A, et al: BMP-4 affects the differentiation of metanephric mesenchyme and reveals an early anterior-posterior axis of the embryonic kidney. Dev Dyn 217:146-158, 2000
12. PERANTONI AO, DOVE L, KARAVANOVA I: Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci USA 92:4696-4700, 1995
13. HATINI V, HUH SO, HERZLINGER D, et al: Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev 10:1467-1478, 1996
14. DUDLEY AT, GODIN RE, ROBERTSON EJ: Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev 13:1601-1613, 1999
15. FOLKMAN J, D'AMORE PA: Blood vessel formation: what is its molecular basis? Cell 87:1153-1155, 1996
16. TEN DIJKE P, YAMASHITA H, SAMPATH TK, et al: Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269:16985-16988, 1994
17. ROSENZWEIG BL, IMAMURA T, OKADOME T, et al: Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636, 1995
18. CUNNINGHAM NS, PARALKAR V, REDDI AH: Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA 89:11740-11744, 1992
19. WILLETTE RN, GU JL, LYSKO PG, et al: BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res 36: 120-125, 1999
20. KIM WJ, MOHAN RR, MOHAN RR, et al: Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: Expression of the platelet-derived growth factor system in cornea. Invest Ophthalmol Vis Sci 40:1364-1372, 1999
21. CUNHA GR, BATTLE E, YOUNG P, et al: Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle. Epi Cell Biol 1:76-83, 1992
22. TAKAHASHI Y, IMANAKA T, TAKANO T: Spatial pattern of smooth muscle differentiation is specified by the epithelium in the stomach of mouse embryo. Dev Dyn 212:448-460, 1999
23. DISANDRO MJ, LI Y, BASKIN LS, et al: Mesenchymal-epithelial interactions in bladder smooth muscle development: Epithelial specificity. J Urol 160:1040-1046, 1998
24. SCHUGER L, SKUBITZ APN, ZHANG J, et al: Laminin α1 chain synthesis in the mouse developmental lung: requirement for epithelium-mesenchymal contact and possible role in bronchial smooth muscle development. J Cell Biol 139:553-562, 1997
25. YANG Y, RELAN NK, PRZYWARA DA, et al: Embryonic mesenchymal cells share the potential for smooth muscle differentiation: Myogenesis is controlled by the cell's shape. Development 126: 3027-3033, 1999